IT1306679B1 - Uso dei derivati dell'acido ialuronico per la preparazione dicomposizoni farmaceutiche e biomateriali per la prevenzione della - Google Patents

Uso dei derivati dell'acido ialuronico per la preparazione dicomposizoni farmaceutiche e biomateriali per la prevenzione della

Info

Publication number: IT1306679B1
Authority: IT; Italy
Prior art keywords: hyaluronic acid; acid derivatives; prevention; preparation; pharmaceutical
Prior art date: 1999-06-29

Application number

IT1999PD000144A

Other languages

English (en)

Inventor

Carbonare Maurizio Dalle

Lanfranco Callegaro

Original Assignee

Fidia Advanced Biopolymers Srl

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1999-06-29

Filing date

1999-06-29

Publication date

2001-10-02

1999-06-29 Priority to IT1999PD000144A priority Critical patent/IT1306679B1/it

1999-06-29 Application filed by Fidia Advanced Biopolymers Srl filed Critical Fidia Advanced Biopolymers Srl

2000-06-29 Priority to US10/019,387 priority patent/US8147811B1/en

2000-06-29 Priority to PCT/EP2000/006087 priority patent/WO2001000190A2/en

2000-06-29 Priority to EP20050027813 priority patent/EP1712228A3/en

2000-06-29 Priority to ES00952981T priority patent/ES2269169T3/es

2000-06-29 Priority to EP00952981A priority patent/EP1196179B8/en

2000-06-29 Priority to DE60030124T priority patent/DE60030124T2/de

2000-06-29 Priority to AT00952981T priority patent/ATE336255T1/de

2000-06-29 Priority to AU65598/00A priority patent/AU6559800A/en

2000-12-29 Publication of ITPD990144A1 publication Critical patent/ITPD990144A1/it

2001-10-02 Application granted granted Critical

2001-10-02 Publication of IT1306679B1 publication Critical patent/IT1306679B1/it

Links

KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical class CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 title abstract 3
239000012620 biological material Substances 0.000 title abstract 2
230000002265 prevention Effects 0.000 title abstract 2
239000000203 mixture Substances 0.000 title 1
208000032544 Cicatrix Diseases 0.000 abstract 1
230000015572 biosynthetic process Effects 0.000 abstract 1
150000001875 compounds Chemical class 0.000 abstract 1
231100000241 scar Toxicity 0.000 abstract 1
230000037387 scars Effects 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
- A61K31/728—Hyaluronic acid
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
- A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
- A61L15/22—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons containing macromolecular materials
- A61L15/28—Polysaccharides or their derivatives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
- A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
- A61L15/42—Use of materials characterised by their function or physical properties
- A61L15/44—Medicaments
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L17/00—Materials for surgical sutures or for ligaturing blood vessels ; Materials for prostheses or catheters
- A61L17/005—Materials for surgical sutures or for ligaturing blood vessels ; Materials for prostheses or catheters containing a biologically active substance, e.g. a medicament or a biocide
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L17/00—Materials for surgical sutures or for ligaturing blood vessels ; Materials for prostheses or catheters
- A61L17/06—At least partially resorbable materials
- A61L17/10—At least partially resorbable materials containing macromolecular materials
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
- A61L31/04—Macromolecular materials
- A61L31/042—Polysaccharides
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
- A61L31/14—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
- A61L31/16—Biologically active materials, e.g. therapeutic substances
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/20—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials
- A61L2300/23—Carbohydrates
- A61L2300/236—Glycosaminoglycans, e.g. heparin, hyaluronic acid, chondroitin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
- A61L2300/404—Biocides, antimicrobial agents, antiseptic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
- A61L2300/412—Tissue-regenerating or healing or proliferative agents
- A61L2300/414—Growth factors
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
- A61L2300/45—Mixtures of two or more drugs, e.g. synergistic mixtures

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
General Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Animal Behavior & Ethology (AREA)
Epidemiology (AREA)
Chemical & Material Sciences (AREA)
Engineering & Computer Science (AREA)
Materials Engineering (AREA)
Molecular Biology (AREA)
Surgery (AREA)
Vascular Medicine (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Heart & Thoracic Surgery (AREA)
Hematology (AREA)
Biomedical Technology (AREA)
Dermatology (AREA)
Bioinformatics & Cheminformatics (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Polysaccharides And Polysaccharide Derivatives (AREA)
Medicinal Preparation (AREA)
Cosmetics (AREA)

IT1999PD000144A 1999-06-29 1999-06-29 Uso dei derivati dell'acido ialuronico per la preparazione dicomposizoni farmaceutiche e biomateriali per la prevenzione della IT1306679B1 (it)

Priority Applications (9)

Application Number	Priority Date	Filing Date	Title
IT1999PD000144A IT1306679B1 (it)	1999-06-29	1999-06-29	Uso dei derivati dell'acido ialuronico per la preparazione dicomposizoni farmaceutiche e biomateriali per la prevenzione della
PCT/EP2000/006087 WO2001000190A2 (en)	1999-06-29	2000-06-29	Hyaluronic acid derivatives for the prevention and treatment of cutaneous scars
EP20050027813 EP1712228A3 (en)	1999-06-29	2000-06-29	Hyaluronic acid derivatives for the prevention and treatment of cutaneous scars
ES00952981T ES2269169T3 (es)	1999-06-29	2000-06-29	Esteres de acido hialuronico para el tratamiento de la cicatrizacion normotrofica de la piel.
US10/019,387 US8147811B1 (en)	1999-06-29	2000-06-29	Use of hyaluronic acid derivatives in pharmaceutical preparations and biomaterials for the prevention and treatment of cutaneous scars
EP00952981A EP1196179B8 (en)	1999-06-29	2000-06-29	Hyaluronic acid esters for the treatment of normotrophic scarring of the skin
DE60030124T DE60030124T2 (de)	1999-06-29	2000-06-29	Hyaluronsäure-ester zur behandlung von normotrophischen hautnarben
AT00952981T ATE336255T1 (de)	1999-06-29	2000-06-29	Hyaluronsäure-ester zur behandlung von normotrophischen hautnarben
AU65598/00A AU6559800A (en)	1999-06-29	2000-06-29	Use of hyaluronic acid derivatives in pharmaceutical preparations and biomaterials for the prevention and treatment of cutaneous scars

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
IT1999PD000144A IT1306679B1 (it)	1999-06-29	1999-06-29	Uso dei derivati dell'acido ialuronico per la preparazione dicomposizoni farmaceutiche e biomateriali per la prevenzione della

Publications (2)

Publication Number	Publication Date
ITPD990144A1 ITPD990144A1 (it)	2000-12-29
IT1306679B1 true IT1306679B1 (it)	2001-10-02

Family

ID=11392667

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
IT1999PD000144A IT1306679B1 (it)	1999-06-29	1999-06-29	Uso dei derivati dell'acido ialuronico per la preparazione dicomposizoni farmaceutiche e biomateriali per la prevenzione della

Country Status (8)

Country	Link
US (1)	US8147811B1 (it)
EP (2)	EP1712228A3 (it)
AT (1)	ATE336255T1 (it)
AU (1)	AU6559800A (it)
DE (1)	DE60030124T2 (it)
ES (1)	ES2269169T3 (it)
IT (1)	IT1306679B1 (it)
WO (1)	WO2001000190A2 (it)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB0107653D0 (en) *	2001-03-27	2001-05-16	Bristol Myers Squibb Co	Wound dressing
ITPD20050168A1 (it) *	2005-06-01	2006-12-02	Fidia Advanced Biopolymers Srl	Formulazioni di acido lipoico ed acido ialuronico e o suoi derivati e loro impiego in campo farmaceutico e cosmetico
ITPD20050207A1 (it)	2005-07-07	2007-01-08	Fidia Farmaceutici	Nuove composizioni farmaceutiche contenenti acido ialuronico e collagenas nel trattamento topico di ferite, ustioni ed ulcere
BRPI0618475B1 (pt)	2005-11-09	2016-10-11	Klox Technologies Inc	composição, método para branqueamento de dentes e kit
US20100266989A1 (en)	2006-11-09	2010-10-21	Klox Technologies Inc.	Teeth whitening compositions and methods
US9228027B2 (en)	2008-09-02	2016-01-05	Allergan Holdings France S.A.S.	Threads of Hyaluronic acid and/or derivatives thereof, methods of making thereof and uses thereof
AU2015201245B2 (en) *	2008-09-02	2016-07-07	Allergan, Inc.	Threads of hyaluronic acid and/or derivatives thereof, methods of making thereof and uses thereof
CN102300587B (zh) *	2008-11-07	2015-04-01	克洛克斯科技公司	用于伤口愈合的氧化剂和光活化剂的组合物
DK2384210T3 (da)	2008-12-02	2017-11-27	Allergan Inc	Injektionsanordning
EP2453922B1 (en)	2009-07-17	2017-10-25	Klox Technologies Inc.	Antibacterial oral composition
US20130281913A1 (en)	2012-04-20	2013-10-24	Klox Technologies Inc.	Biophotonic compositions and methods for providing biophotonic treatment
US11116841B2 (en)	2012-04-20	2021-09-14	Klox Technologies Inc.	Biophotonic compositions, kits and methods
ITPD20120173A1 (it)	2012-05-31	2013-12-01	Fidia Farmaceutici	"nuovo sistema di rilascio di proteine idrofobiche"
EP2895139B1 (en)	2012-09-14	2019-10-23	Bausch Health Companies Inc.	Methods for teeth whitening
WO2014165113A1 (en) *	2013-03-12	2014-10-09	Allergan Holdings France S.A.S.	Cross-linked hyaluronic acid threads for treatment of striae
US20140276354A1 (en)	2013-03-14	2014-09-18	Klox Technologies Inc.	Biophotonic materials and uses thereof
US20140350518A1 (en)	2013-05-23	2014-11-27	Allergan, Inc.	Syringe extrusion accessory
KR20210108505A (ko)	2013-07-03	2021-09-02	광동 클록스 바이오메디컬 그룹 씨오., 엘티디	상처를 치료하기 위한 발색단과 겔화제를 포함하는 생체광자성 조성물
ES2791290T3 (es)	2014-01-27	2020-11-03	Allergan Holdings France S A S	Dispositivo de administración de sustancias
WO2015149177A1 (en)	2014-04-01	2015-10-08	Klox Technologies Inc.	Tissue filler compositions and methods of use
US10029048B2 (en)	2014-05-13	2018-07-24	Allergan, Inc.	High force injection devices
US10226585B2 (en)	2014-10-01	2019-03-12	Allergan, Inc.	Devices for injection and dosing
AU2015337786B2 (en)	2014-10-31	2020-03-26	Klox Technologies Inc.	Photoactivatable fibers and fabric media
CA2976544A1 (en)	2015-03-10	2016-09-15	Allergan Pharmaceuticals Holdings (Ireland) Unlimited Company	Multiple needle injector
KR102288170B1 (ko)	2016-04-08	2021-08-09	알레간 인코포레이티드	흡인 및 주입 디바이스
US10265151B2 (en)	2017-01-24	2019-04-23	Allergan Industrie Sas	Thread insertion devices
US10258447B2 (en)	2017-01-24	2019-04-16	Allergan Industrie Sas	Thread insertion devices
US10595977B2 (en)	2017-01-24	2020-03-24	Allergan Industrie, Sas	Thread insertion devices
US10820900B2 (en)	2017-01-24	2020-11-03	Allergan Industrie Sas	Thread insertion devices
US10709444B2 (en)	2017-01-24	2020-07-14	Allergan Industrie Sas	Thread insertion devices
USD867582S1 (en)	2017-03-24	2019-11-19	Allergan, Inc.	Syringe device

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4851521A (en) *	1985-07-08	1989-07-25	Fidia, S.P.A.	Esters of hyaluronic acid
IT1219587B (it) *	1988-05-13	1990-05-18	Fidia Farmaceutici	Polisaccaridi carbossiilici autoreticolati
IT1248934B (it) *	1990-06-01	1995-02-11	Fidia Spa	Membrane forate biocompatibili,processi per la loro preparazione,loro impiego come supporto per la crescita in vitro di cellule epiteliali, pelli artificiali cosi' ottenute e loro impiego nei trapianti di pelle
US5824335A (en) *	1991-12-18	1998-10-20	Dorigatti; Franco	Non-woven fabric material comprising auto-crosslinked hyaluronic acid derivatives
IT1263316B (it) *	1993-02-12	1996-08-05	Fidia Advanced Biopolymers Srl	Tessuto non tessuto multistrato in cui uno degli strati e' costituito essenzialmente da esteri dell'acido ialuronico
NZ316944A (en) *	1995-08-29	1999-08-30	Fidia Advanced Biopolymers Srl	Composite biomaterial for preventing surgical adhesions of tissue containing hyaluronic acid derivative
WO1997045532A1 (en) *	1996-05-28	1997-12-04	Brown University Research Foundation	Hyaluronan based biodegradable scaffolds for tissue repair
IT1294797B1 (it) *	1997-07-28	1999-04-15	Fidia Advanced Biopolymers Srl	Uso dei derivati dell'acido ialuronico nella preparazione di biomateriali aventi attivita' emostatica fisica e tamponante

1999
- 1999-06-29 IT IT1999PD000144A patent/IT1306679B1/it active
2000
- 2000-06-29 DE DE60030124T patent/DE60030124T2/de not_active Expired - Lifetime
- 2000-06-29 EP EP20050027813 patent/EP1712228A3/en not_active Withdrawn
- 2000-06-29 EP EP00952981A patent/EP1196179B8/en not_active Expired - Lifetime
- 2000-06-29 AT AT00952981T patent/ATE336255T1/de active
- 2000-06-29 US US10/019,387 patent/US8147811B1/en not_active Expired - Fee Related
- 2000-06-29 ES ES00952981T patent/ES2269169T3/es not_active Expired - Lifetime
- 2000-06-29 AU AU65598/00A patent/AU6559800A/en not_active Abandoned
- 2000-06-29 WO PCT/EP2000/006087 patent/WO2001000190A2/en not_active Ceased

Also Published As

Publication number	Publication date
EP1712228A3 (en)	2009-03-18
ITPD990144A1 (it)	2000-12-29
WO2001000190A3 (en)	2001-08-16
EP1712228A2 (en)	2006-10-18
AU6559800A (en)	2001-01-31
US8147811B1 (en)	2012-04-03
DE60030124D1 (de)	2006-09-28
WO2001000190A2 (en)	2001-01-04
ATE336255T1 (de)	2006-09-15
EP1196179B1 (en)	2006-08-16
DE60030124T2 (de)	2007-03-29
EP1196179B8 (en)	2006-10-11
EP1196179A2 (en)	2002-04-17
ES2269169T3 (es)	2007-04-01

Publication	Publication Date	Title
IT1306679B1 (it)	2001-10-02	Uso dei derivati dell'acido ialuronico per la preparazione dicomposizoni farmaceutiche e biomateriali per la prevenzione della
BR9711805A (pt)	2002-01-15	Compostos e métodos para providenciar preparações farmacologicamente ativas e uso dos mesmos
WO1997030677A3 (en)	1997-11-20	Pentafluorobenzenesulfonamides and analogs
IT1288290B1 (it)	1998-09-11	Acido ialuronico autoreticolato e relative composizioni farmaceutiche per il trattamento delle artropatie
UA56989C2 (uk)	2003-06-16	ФІЗІОЛОГІЧНО АКТИВНИЙ ПЕГ-КОН'ЮГАТ <font face="Symbol">a</font>-ІНТЕРФЕРОНУ, СПОСІБ ЙОГО ОДЕРЖАННЯ, ФАРМАЦЕВТИЧНА КОМПОЗИЦІЯ НА ЙОГО ОСНОВІ ТА СПОСІБ ЛІКУВАННЯ АБО ПРОФІЛАКТИКИ ІМУНОМОДУЛЯТОРНИХ ЗАХВОРЮВАНЬ
PT1005453E (pt)	2005-02-28	Compostos de benzeno substituido como agentes de reducao antiproliferativa
EP0804595A4 (it)	1997-11-05
ATE452640T1 (de)	2010-01-15	Mittel für erkrankungen assoziert mit knochensubstanzverlust
IL142066A0 (en)	2002-03-10	Arylsulfonanilide urea derivatives and pharmaceutical compositions containing the same
BRPI9909282B8 (pt)	2021-07-06	compostos de Éter aminociclohexÍlicos e usos dos mesmos.
ATE249214T1 (de)	2003-09-15	Pentafluorobenzensulfonamide und analoge
PT1222195E (pt)	2004-05-31	Novos compostos de tiazolo(4,5-d)pirimidina
DE69839939D1 (de)	2008-10-09	Tropoelastinderivate
HK1045816A1 (zh)	2002-12-13	角质细胞生长因子-2制剂
DE69919179D1 (de)	2004-09-09	Substituierte gamma-phenyl-delta-lactone und deren analoge, und ihre verwendungen
EA200200914A1 (ru)	2003-02-27	Система контроля дозирования для однократного ежедневного приема назначенного ципрофлоксацина
DE69911017D1 (en)	2003-10-09	Arylsulfonanilid-phosphate
BR0011845A (pt)	2002-03-05	Complexo farmacêutico
DE59101818D1 (de)	1994-07-14	Arzneimittelzubereitung, enthaltend Stigmasta-4-en-3-on sowie deren Verwendung.
BR0016168A (pt)	2002-08-20	Combinações terapêuticas de (s)-2-(benzilaminometil)-2,3,8,9tetrahidro-7h-1,4-dioxi no[2,3 -e]indol-8-ona e neurolépticos para o tratamento ou prevenção de distúrbios psicóticos
ATE218366T1 (de)	2002-06-15	Pharmazeutische zusammensetzung enthaltend factor xiiia für nervenheilung
ITFI990097A0 (it)	1999-04-27	Composizioni farmaceutiche contenenti inibitori dell'ormone della crescita o loro frammenti biologicamente attivi per il trattamento
ECSP993181A (es)	1999-12-23	Procedimiento para la preparacion de una composicion de alta pureza de (7alfa, 17alfa)- 17 - hidroxi-7-19-nor-17- pregn-5(10) -en -20-in-3-ona
ITRM990633A0 (it)	1999-10-15	Derivati polinucleari di ti(v) con leganti 4-acil-5-pirazolonati ad attivita' antitumorale e procedimento per la loro produzione.